title: Intracorporeal papaverine injection in androgen deprived men.
abstract: The intracorporeal injection of papaverine (ICP) is now a well recognized therapeutic option in the management of impotence. The current treatment of advanced prostatic carcinoma causes erectile failure. Although intracorporeal papaverine can induce erections in these men, libido is also reduced so that the role of ICP is limited to those men complying with the wishes of a highly motivated partner.
authors.affiliation: Department of Urology, Southmead Hospital, Westbury-on-Trym, Bristol.
authors.forename: H W
authors.initials: HW
authors.lastname: Gilbert
authors.forename: D A
authors.initials: DA
authors.lastname: Gillatt
authors.forename: K M
authors.initials: KM
authors.lastname: Desai
authors.forename: J C
authors.initials: JC
authors.lastname: Gingell
mesh_terms: D007172:Erectile Dysfunction / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D007267:Injections; D007989:Libido / Q000187:drug effects; D008297:Male; D015337:Multicenter Studies as Topic; D010208:Papaverine / Q000008:administration & dosage* / Q000627:therapeutic use; D010410:Penile Erection / Q000187:drug effects*; D011471:Prostatic Neoplasms / Q000188:drug therapy
chemical_list: D010208:Papaverine